Now available POMALIDOMIDE

Pomalidomide capsules are indicated for the treatment of:

Multiple Myeloma
Pomalidomide, in combination with dexamethasone, are indicated for adult patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Kaposi Sarcoma
Pomalidomide capsules are indicated for the treatment of:

• Adult patients with AIDS-related Kaposi sarcoma (KS) after failure of highly active antiretroviral therapy (HAART).
• Kaposi sarcoma  (KS) in adult patients who are HIV-negative.

Please see full prescribing information here.